George, D. J., Agarwal, N., Ramaswamy, K., Klaassen, Z., Bitting, R. L., Russell, D., … Freedland, S. J. (2025). Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States? Future Oncol, 21(11), 1307–1315. https://doi.org/10.1080/14796694.2025.2485763

George, Daniel J., Neeraj Agarwal, Krishnan Ramaswamy, Zachary Klaassen, Rhonda L. Bitting, David Russell, Rickard Sandin, et al. “Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?” Future Oncol 21, no. 11 (May 2025): 1307–15. https://doi.org/10.1080/14796694.2025.2485763.

George DJ, Agarwal N, Ramaswamy K, Klaassen Z, Bitting RL, Russell D, et al. Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States? Future Oncol. 2025 May;21(11):1307–15.

George, Daniel J., et al. “Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?” Future Oncol, vol. 21, no. 11, May 2025, pp. 1307–15. Pubmed, doi:10.1080/14796694.2025.2485763.

George DJ, Agarwal N, Ramaswamy K, Klaassen Z, Bitting RL, Russell D, Sandin R, Emir B, Yang H, Song W, Lin Y, Hong A, Gao W, Freedland SJ. Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States? Future Oncol. 2025 May;21(11):1307–1315.